These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

553 related items for PubMed ID: 16418010

  • 1. Biomarker discovery from the plasma proteome using multidimensional fractionation proteomics.
    Lee HJ, Lee EY, Kwon MS, Paik YK.
    Curr Opin Chem Biol; 2006 Feb; 10(1):42-9. PubMed ID: 16418010
    [Abstract] [Full Text] [Related]

  • 2. Plasma-derived microparticles for biomarker discovery.
    Smalley DM, Ley K.
    Clin Lab; 2008 Feb; 54(3-4):67-79. PubMed ID: 18630736
    [Abstract] [Full Text] [Related]

  • 3. Efficient prefractionation of low-abundance proteins in human plasma and construction of a two-dimensional map.
    Cho SY, Lee EY, Lee JS, Kim HY, Park JM, Kwon MS, Park YK, Lee HJ, Kang MJ, Kim JY, Yoo JS, Park SJ, Cho JW, Kim HS, Paik YK.
    Proteomics; 2005 Aug; 5(13):3386-96. PubMed ID: 16047310
    [Abstract] [Full Text] [Related]

  • 4. Sample preparation and fractionation for proteome analysis and cancer biomarker discovery by mass spectrometry.
    Ahmed FE.
    J Sep Sci; 2009 Mar; 32(5-6):771-98. PubMed ID: 19219839
    [Abstract] [Full Text] [Related]

  • 5. Clinical perspectives of high-resolution mass spectrometry-based proteomics in neuroscience: exemplified in amyotrophic lateral sclerosis biomarker discovery research.
    Ekegren T, Hanrieder J, Bergquist J.
    J Mass Spectrom; 2008 May; 43(5):559-71. PubMed ID: 18416436
    [Abstract] [Full Text] [Related]

  • 6. Applying proteomics technology to platelet research.
    García A, Watson SP, Dwek RA, Zitzmann N.
    Mass Spectrom Rev; 2005 May; 24(6):918-30. PubMed ID: 15599945
    [Abstract] [Full Text] [Related]

  • 7. Biomarker discovery for kidney diseases by mass spectrometry.
    Niwa T.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jul 15; 870(2):148-53. PubMed ID: 18024247
    [Abstract] [Full Text] [Related]

  • 8. Recent advances in mass spectrometry-based peptidome analysis.
    Hu L, Ye M, Zou H.
    Expert Rev Proteomics; 2009 Aug 15; 6(4):433-47. PubMed ID: 19681678
    [Abstract] [Full Text] [Related]

  • 9. Clinical proteomics: the promises and challenges of mass spectrometry-based biomarker discovery.
    deVera IE, Katz JE, Agus DB.
    Clin Adv Hematol Oncol; 2006 Jul 15; 4(7):541-9. PubMed ID: 17147241
    [Abstract] [Full Text] [Related]

  • 10. Contribution of protein fractionation to depth of analysis of the serum and plasma proteomes.
    Faca V, Pitteri SJ, Newcomb L, Glukhova V, Phanstiel D, Krasnoselsky A, Zhang Q, Struthers J, Wang H, Eng J, Fitzgibbon M, McIntosh M, Hanash S.
    J Proteome Res; 2007 Sep 15; 6(9):3558-65. PubMed ID: 17696519
    [Abstract] [Full Text] [Related]

  • 11. Peptidomic analysis of human blood specimens: comparison between plasma specimens and serum by differential peptide display.
    Tammen H, Schulte I, Hess R, Menzel C, Kellmann M, Mohring T, Schulz-Knappe P.
    Proteomics; 2005 Aug 15; 5(13):3414-22. PubMed ID: 16038021
    [Abstract] [Full Text] [Related]

  • 12. Analysis of human serum by liquid chromatography-mass spectrometry: improved sample preparation and data analysis.
    Govorukhina NI, Reijmers TH, Nyangoma SO, van der Zee AG, Jansen RC, Bischoff R.
    J Chromatogr A; 2006 Jul 07; 1120(1-2):142-50. PubMed ID: 16574134
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of three principally different intact protein prefractionation methods for plasma biomarker discovery.
    Pernemalm M, Orre LM, Lengqvist J, Wikström P, Lewensohn R, Lehtiö J.
    J Proteome Res; 2008 Jul 07; 7(7):2712-22. PubMed ID: 18549256
    [Abstract] [Full Text] [Related]

  • 14. Global and targeted quantitative proteomics for biomarker discovery.
    Veenstra TD.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb 15; 847(1):3-11. PubMed ID: 17023222
    [Abstract] [Full Text] [Related]

  • 15. Clinical proteomics and biomarker discovery.
    Johann DJ, McGuigan MD, Patel AR, Tomov S, Ross S, Conrads TP, Veenstra TD, Fishman DA, Whiteley GR, Petricoin EF, Liotta LA.
    Ann N Y Acad Sci; 2004 Jun 15; 1022():295-305. PubMed ID: 15251975
    [Abstract] [Full Text] [Related]

  • 16. An integrated serum proteomic approach capable of monitoring the low molecular weight proteome with sequencing of intermediate to large peptides.
    Merrell K, Thulin CD, Esplin MS, Graves SW.
    Rapid Commun Mass Spectrom; 2009 Sep 15; 23(17):2685-96. PubMed ID: 19630037
    [Abstract] [Full Text] [Related]

  • 17. Recent advances in clinical proteomics using mass spectrometry.
    Dowling P, Meleady P, Henry M, Clynes M.
    Bioanalysis; 2010 Sep 15; 2(9):1609-15. PubMed ID: 21083289
    [Abstract] [Full Text] [Related]

  • 18. Targeted proteomics in biomarker validation: detection and quantification of proteins using a multi-dimensional peptide separation strategy.
    Immler D, Greven S, Reinemer P.
    Proteomics; 2006 May 15; 6(10):2947-58. PubMed ID: 16619308
    [Abstract] [Full Text] [Related]

  • 19. Fractionation of the human plasma proteome for monoclonal antibody proteomics-based biomarker discovery.
    Kovács A, Sperling E, Lázár J, Balogh A, Kádas J, Szekrényes A, Takács L, Kurucz I, Guttman A.
    Electrophoresis; 2011 Aug 15; 32(15):1916-25. PubMed ID: 21732557
    [Abstract] [Full Text] [Related]

  • 20. Recent progress in selected reaction monitoring MS-driven plasma protein biomarker analysis.
    Chiu CL, Randall S, Molloy MP.
    Bioanalysis; 2009 Jul 15; 1(4):847-55. PubMed ID: 21083142
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.